BidaskClub lowered shares of Healthequity (NASDAQ:HQY) from a buy rating to a hold rating in a research note issued to investors on Friday.
A number of other research analysts also recently commented on HQY. Raymond James lifted their price objective on shares of Healthequity from $85.00 to $105.00 and gave the company an outperform rating in a research report on Monday, September 10th. Bank of America downgraded shares of Healthequity from a buy rating to a neutral rating and lifted their price objective for the company from $84.00 to $105.00 in a research report on Thursday, September 6th. They noted that the move was a valuation call. SunTrust Banks lifted their price objective on shares of Healthequity to $105.00 and gave the company a buy rating in a research report on Wednesday, September 5th. Cantor Fitzgerald lifted their price objective on shares of Healthequity from $68.00 to $80.00 and gave the company a neutral rating in a research report on Wednesday, September 5th. Finally, Citigroup reissued a buy rating and issued a $110.00 price objective on shares of Healthequity in a research report on Wednesday, September 5th. Six equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The company has an average rating of Buy and a consensus target price of $90.92.
Healthequity stock opened at $68.38 on Friday. The firm has a market capitalization of $4.59 billion, a P/E ratio of 126.63, a price-to-earnings-growth ratio of 2.72 and a beta of 1.37. Healthequity has a 1-year low of $42.92 and a 1-year high of $101.58.
Healthequity (NASDAQ:HQY) last released its earnings results on Tuesday, December 4th. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.20 by $0.02. The business had revenue of $70.50 million during the quarter, compared to the consensus estimate of $69.60 million. Healthequity had a net margin of 24.52% and a return on equity of 12.42%. The firm’s revenue for the quarter was up 24.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.17 earnings per share. On average, equities analysts forecast that Healthequity will post 0.87 EPS for the current year.
In other news, VP Darcy G. Mott sold 4,000 shares of the firm’s stock in a transaction dated Tuesday, November 20th. The shares were sold at an average price of $76.91, for a total transaction of $307,640.00. Following the completion of the sale, the vice president now owns 89,500 shares in the company, valued at approximately $6,883,445. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In the last 90 days, insiders have sold 12,000 shares of company stock valued at $1,027,400. 4.00% of the stock is currently owned by corporate insiders.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Clearbridge Investments LLC lifted its stake in shares of Healthequity by 976,643.6% during the 3rd quarter. Clearbridge Investments LLC now owns 380,930 shares of the company’s stock worth $35,964,000 after buying an additional 380,891 shares during the last quarter. Morgan Stanley lifted its stake in shares of Healthequity by 15.5% during the 3rd quarter. Morgan Stanley now owns 4,001,425 shares of the company’s stock worth $377,775,000 after buying an additional 536,366 shares during the last quarter. Rehmann Capital Advisory Group lifted its stake in shares of Healthequity by 9,128.0% during the 3rd quarter. Rehmann Capital Advisory Group now owns 98,186 shares of the company’s stock worth $1,040,000 after buying an additional 97,122 shares during the last quarter. New Mexico Educational Retirement Board acquired a new stake in shares of Healthequity during the 3rd quarter worth about $1,171,000. Finally, Teachers Advisors LLC lifted its stake in shares of Healthequity by 1.7% during the 3rd quarter. Teachers Advisors LLC now owns 110,397 shares of the company’s stock worth $10,423,000 after buying an additional 1,845 shares during the last quarter. Institutional investors own 93.01% of the company’s stock.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Further Reading: Yield Curve
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.